M.-C. Fournié-Zaluski

Neuroscience · Life Sciences

23h-index2.1kcitations60works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neuropeptides and Animal Physiology(35), Pain Mechanisms and Treatments(15), Receptor Mechanisms and Signaling(15), Peptidase Inhibition and Analysis(13), HIV Research and Treatment(5)

Publications60 total

Leukotriene A4 Hydrolase Complexed with KELatorphan
2007
[E296Q]LTA4H in complex with Arg-Ala-Arg substrate
2007
Leukotriene A4 Hydrolase Complexed with Inhibitor RB3040
2007
[E296Q]LTA4H in complex with RSR substrate
2007
Brain renin-angiotensin system blockade by systemically active aminopeptidase A inhibitors: A potential treatment of salt-dependent hypertension
Proceedings of the National Academy of Sciences·2004· 132 citedOpen Access
First discrete autoradiographic distribution of aminopeptidase N in various structures of rat brain and spinal cord using the selective iodinated inhibitor [125I]RB 129
Neuroscience·2001· 65 citedOpen Access
Acute effect of the dual angiotensin‐converting enzyme and neutral endopeptidase 24‐11 inhibitor mixanpril on insulin sensitivity in obese Zucker rat
British Journal of Pharmacology·2001· 46 citedOpen Access
Aminopeptidase A, which generates one of the main effector peptides of the brain renin‒angiotensin system, angiotensin III, has a key role in central control of arterial blood pressure
Biochemical Society Transactions·2000· 23 cited
Effects of combined neutral endopeptidase 24‐11 and angiotensin‐converting enzyme inhibition on femoral vascular conductance in streptozotocin‐induced diabetic rats
British Journal of Pharmacology·2000· 18 citedOpen Access
SOLUTION STRUCTURE OF NCP7 FROM HIV-1
2000
A mimic of HIV-1 nucleocapsid protein impairs reverse transcription and displays antiviral activity
Proceedings of the National Academy of Sciences·1999· 41 cited
A three-dimensional construction of the active site (region 507–749) of human neutral endopeptidase (EC.3.4.24.11)
Protein Engineering Design and Selection·1999· 52 cited
HIV‐1ヌクレオカプシド蛋白質模倣体は逆転写を阻害し,抗ウイルス活性を示す
Proc Natl Acad Sci USA·1999· 19 cited
Model of the complex formed between the H2 domain of the TATA box binding protein and the L(281-301) fragment of the human transcription factor TFIIA
Protein Engineering Design and Selection·1998· 6 citedOpen Access
Synthesis and biological activities of fluorescent acridine‐containing HIV‐1 nucleocapsid proteins for investigation of nucleic acid‐NCp7 interactions
Journal of Peptide Research·1997· 15 cited
CI 988, an antagonist of the cholecystokinin-B receptor, potentiates endogenous opioid-mediated antinociception at spinal level
Neuropeptides·1997· 16 cited
Antinociceptive Effects of RB101, a Complete Inhibitor of Enkephalin-catabolizing Enzymes, Are Enhanced by a Cholecystokinin Type B Receptor Antagonist, as Revealed by Noxiously Evoked Spinal c-Fos Expression in Rats
Journal of Pharmacology and Experimental Therapeutics·1997· 17 cited
Opposite role of δ1- and δ2-opioid receptors activated by endogenous or exogenous opioid agonists on the endogenous cholecystokinin system: further evidence for δ-opioid receptor heterogeneity
Neuroscience·1996· 24 cited
Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release.
Proceedings of the National Academy of Sciences·1996· 319 citedOpen Access
Similar decrease in spontaneous morphine abstinence by methadone and RB 101, an inhibitor of enkephalin catabolism
British Journal of Pharmacology·1996· 24 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

B.P. Roques(35), B. P. Roques(8), Rafaël Maldonado(8), G. Gacel(6), Catherine Llorens‐Cortés(4), B P Roques(4), Ann Beaumont(4), Hugues de Rocquigny(3), Philippe Crine(3), Florence Noble(3), Olga Valverde(3), J. Peyroux(3), Jean-Marc Soleilhac(3), P Corvol(2), J L Darlix(2), Nelly Morellet(2), Nathalie Jullian(2), Annabelle Réaux‐Le Goazigo(2), René Lai–Kuen(2), Jean Féger(2)